A novel homozygous mutation (Gly1715Ser) causing hereditary factor V deficiency in a Chinese patient

被引:4
作者
Liu, Siqi [1 ]
Luo, Shasha [1 ]
Yang, Lihong [1 ]
Jin, Yanhui [1 ]
Xie, Haixiao [1 ]
Xie, Yaosheng [1 ]
Li, Xiaolong [1 ]
Wang, Mingshan [1 ]
机构
[1] Wenzhou Med Univ, Affiliated Hosp 1, Dept Clin Lab, Wenzhou 325000, Peoples R China
关键词
F5; gene; factor V deficiency; hemorrhagic disease; missense mutation; COAGULATION-FACTOR-V; CATALYZED ACTIVATION; MANAGEMENT; DIAGNOSIS; R506Q;
D O I
10.1097/MBC.0000000000000871
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
To explore the phenotype and genotype of a Chinese family with hereditary factor V deficiency. Routine blood coagulation indexes were detected by one-stage clotting method, whereas factor V antigen was detected by ELISA. All exons and intron-exon boundaries of F5 gene were amplified by PCR and sequenced directly. The suspected mutation was confirmed by reverse sequencing. Bioinformatics softwares were used to analyze the possible impact of this mutation. Phenotypic analysis showed that the proband had significantly prolonged prothrombin time and activated partial thromboplastin time, and his factor V clotting activity was decreased to 3%. Genetic analysis revealed a homozygous missense mutation c.5227G>A (p.Gly1715Ser) in exon 16 of F5 gene. Bioinformatics and structural analysis demonstrated this mutation was deleterious and could affect the integrity of local intermolecular structures. The missense mutation (Gly1715Ser) was responsible for the decrease of factor V clotting activity and factor V antigen in this family, and caused type I hereditary factor V deficiency.
引用
收藏
页码:71 / 76
页数:6
相关论文
共 17 条
[1]   Diagnosis and management of factor V Leiden [J].
Campello, Elena ;
Spiezia, Luca ;
Simioni, Paolo .
EXPERT REVIEW OF HEMATOLOGY, 2016, 9 (12) :1139-1149
[2]   Combinations of 4 mutations (FV R506Q, FVH1299R, FVY1702C, PT 20210G/A) affecting the prothrombinase complex in a thrombophilic family [J].
Castoldi, E ;
Simioni, P ;
Kalafatis, M ;
Lunghi, B ;
Tormene, D ;
Girelli, D ;
Girolami, A ;
Bernardi, F .
BLOOD, 2000, 96 (04) :1443-1448
[3]   Procoagulant and anticoagulant properties of coagulation factor V:: Factor V Leiden (APC resistance) causes hypercoagulability by dual mechanisms [J].
Dahlbäck, B .
JOURNAL OF LABORATORY AND CLINICAL MEDICINE, 1999, 133 (05) :415-422
[4]   Factor 5 mutation profile in German patients with homozygous and heterozygous factor V deficiency [J].
Delev, D. ;
Pavlova, A. ;
Heinz, S. ;
Seifried, E. ;
Oldenburg, J. .
HAEMOPHILIA, 2009, 15 (05) :1143-1153
[5]   Diagnosis, clinical manifestations and management of rare bleeding disorders in Iran [J].
Dorgalaleh, Akbar ;
Alavi, Sayed Ezatolla Rafiee ;
Tabibian, Shadi ;
Soori, Shahrzad ;
Moradi, Es'hagh ;
Bamedi, Taregh ;
Asadi, Mansour ;
Jalalvand, Masumeh ;
Shamsizadeh, Morteza .
HEMATOLOGY, 2017, 22 (04) :224-230
[6]   Advances in understanding the bleeding diathesis in factor V deficiency [J].
Duckers, Connie ;
Simioni, Paolo ;
Rosing, Jan ;
Castoldi, Elisabetta .
BRITISH JOURNAL OF HAEMATOLOGY, 2009, 146 (01) :17-26
[7]  
FOSTER WB, 1983, J BIOL CHEM, V258, P3970
[8]   COMPLETE CDNA AND DERIVED AMINO-ACID-SEQUENCE OF HUMAN FACTOR-V [J].
JENNY, RJ ;
PITTMAN, DD ;
TOOLE, JJ ;
KRIZ, RW ;
ALDAPE, RA ;
HEWICK, RM ;
KAUFMAN, RJ ;
MANN, KG .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (14) :4846-4850
[9]   A novel factor V mutation causes a normal activated protein C ratio despite the presence of a heterozygous F5 R506Q (factor V Leiden) mutation [J].
Prueller, Florian ;
Raggam, Reinhard B. ;
Mangge, Harald ;
Truschnig-Wilders, Martie ;
Matzhold, Eva-Maria ;
Weiss, Eva-Christine ;
Hasiba, Barbara ;
Summers, Kelli L. ;
Renner, Wilfried ;
Siegert, Gabriele ;
Kostka, Heike .
BRITISH JOURNAL OF HAEMATOLOGY, 2013, 163 (03) :414-417
[10]  
Rosing J, 1997, THROMB HAEMOSTASIS, V78, P427